Real-time enrollment status for this advanced solid tumor clinical trial
Current Status
Recruiting
Checked: October 22, 2026 at 11:25 AM UTC
| NCT Number | NCT06545942 |
| Recruiting Status | Recruiting |
| Condition | Advanced Solid Tumor |
| Phase | PHASE1 |
| Target Enrollment | 220 participants |
| Active Locations | 12 sites in the US |
| Sponsor | MOMA Therapeutics |
| Last Updated on CT.gov | July 23, 2026 (Jul 23, 2026) |
As of October 22, 2026: Clinical trial NCT06545942 is currently recruiting participants. This phase1 study for advanced solid tumor is actively seeking new participants at 12 locations across the United States. The study is sponsored by MOMA Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06545942 is actively recruiting participants as of October 22, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06545942 was last updated Jul 23, 2026 (July 23, 2026). HelloStudys verifies this status automatically.